from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1222/rseA

LFCtreatmentdescriptionclass of inhibitor

0.408

Amikacinug/mL Amikacintranslation

-0.059

Cap5-10ug/mL Capreomycintranslation

1.620

Rox10-50 ug/mL Roxithromycintranslation

0.837

SM2-5 ug/mL Streptomycintranslation

0.756

Tet5-10 ug/mL Tetracyclinetranslation

-0.716

Rif0.2-5ug/mL Rifampicintranscription

-0.857

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.034

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.146

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.056

CPZ10-50 ug/mL Chlorpromazinerespiration

0.342

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.327

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.416

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.165

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.372

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.240

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.317

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.258

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.020

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.293

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.573

KCN5-20 ug/mL Potassium cyaniderespiration

-0.111

NaN30.2-2 mM Sodium aziderespiration

0.718

Nigericin50 uM Nigericinrespiration

0.131

TRC10-150 ug/mL Triclosanrespiration

0.711

TRZ10-25 ug/mL Thioridazinerespiration

-0.513

Valinomycin0.5-10 uM Valinomycinrespiration

-0.296

ZnSO42 mM ZnSO4respiration

0.056

menadione6-10 ug/mL Menadionerespiration

-0.351

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.885

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.430

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.537

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.510

NRP_1Non-replicating persistence stage 1dosRassociated

-0.175

Amp0.2mg/mL AmpicillincellWall

-0.678

Cephalexin20-100 ug/mL CephalexincellWall

-0.484

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.722

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.016

EMB10-20 ug/mL EthambutolcellWall

0.295

Eta12-40 ug/mL EthionamidecellWall

-0.202

INH0.2-0.4 ug/mL IsoniazidcellWall

0.046

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.505

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.045

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.216

BZA0.12 mg/mL BenzamidearomaticAmides

-0.202

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.603

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.675

H2O24 mM hydrogen peroxideDNAdamaging

-0.653

Levo10 ug/mL LevofloxacinDNAdamaging

-0.830

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.240

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.875

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.941

UVUV-irradiationDNAdamaging

2.991

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.874

Antimycin12.5-50 ug/mL Antimycin A?

-0.714

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.788

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.882

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.036

PA8240.2-2 ug/mL PA-824?

0.510

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.184

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.308

Verapamil50 uM Verapamil?

-0.804

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.759

methoxatin10-20 ug/mL Methoxatin?